---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-26-000055"
form_type: "8-K"
ticker: "ASPI"
cik: "0001921865"
company_name: "ASP Isotopes Inc."
filed_at: "2026-01-07T23:59:59+00:00"
generated_at: "2026-05-16T11:25:27.010236+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# ASP Isotopes closes acquisition of Renergen; issues 14.27M shares; new execs appointed

## Summary
- Acquired all Renergen shares via scheme of arrangement; exchange ratio 0.09196 ASPI share per Renergen share.
- Issued 14,270,000 shares; Renergen becomes wholly owned subsidiary; delisted from JSE, ASX, A2X.
- Combined company targets helium and isotopes; Renergen's Virginia Gas project has $40M US DFC funding plus expected $500M DFC and $250M Standard Bank debt facilities.
- Renergen CEO Stefano Marani appointed President, Electronics and Space; COO Nick Mitchell appointed Co-COO.
- Inducement grants of 700,000 restricted shares each to Marani and Mitchell, vesting over four years.

## SEC filing metadata
- accession: 0001477932-26-000055
- form_type: 8-K
- ticker: ASPI
- cik: 0001921865
- company_name: ASP Isotopes Inc.
- filed_at: 2026-01-07T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1921865/000147793226000055/0001477932-26-000055-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1921865/000147793226000055/aspi_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-26-000055
- JSON: https://secwatch.observer/filing/0001477932-26-000055.json
- Plain text: https://secwatch.observer/filing/0001477932-26-000055.txt

## Source-grounded claims
- claim_id: 86d5d113628b0b930da9f7d6ed206df2d7cf3edf
  claim: ASP Isotopes Inc. completed an acquisition involving Renergen Limited (closed 2026-01-06).
  evidence_excerpt: On the Closing Date, ASP Isotopes acquired all of the issued Renergen Ordinary Shares from Renergen shareholders in exchange for shares of Company Common Stock at an exchange ratio of 0.09196 shares of Company Common Stock for each Renergen Ordinary Share (the “Consideration Shares”) through the implementation of the Scheme, resulting in the issuance of an aggregate of 14,270,000 Consideration Shares.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1921865/000147793226000055/0001477932-26-000055-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.